October 10, 2022
Harm or illness in our most complicated organ — the human mind — might be laborious to detect and even tougher to deal with. Advancing applied sciences for mind well being requires interdisciplinary collaboration from clinicians and engineers in fields that vary from information science to medication.
This fall the College of Washington’s annual Engineering Lecture Collection will function analysis with potential to rework mind therapeutics from infancy to late maturity. Two UW engineers will discuss their work — on detecting and treating Alzheimer’s illness in addition to on creating therapies for youngsters’s brains. These lectures are free and open to the general public, and this 12 months they are going to be each in particular person and livestreamed. Registration is required.
From discovery to design: Towards early detection and remedy of Alzheimer’s illness
The sequence kicks off Oct. 13, at 7:30 p.m. in Kane Corridor 130 with Valerie Daggett, a professor of bioengineering. Daggett has been learning misfolded proteins that lead ailments corresponding to Alzheimer’s, in addition to Parkinson’s and others, for the reason that Nineties. Greater than 5 million People reside with Alzheimer’s illness — a quantity projected to rise to 14 million by 2050 — and presently, there is no such thing as a treatment. Daggett’s analysis makes use of computational and experimental strategies to design diagnostic and therapeutic brokers to focus on these ailments. This work has been spun out to kind an organization with a promising platform for early prognosis and remedy of Alzheimer’s. Hear from Daggett concerning the know-how and collaborations driving this analysis.
Engineering therapies for the pediatric mind
On Oct. 26, at 7:30 p.m. in Kane Corridor 130, Elizabeth Nance, an affiliate professor of chemical engineering and of bioengineering, will speak about creating therapeutics for new child and pediatric mind illness, with the aim of enhancing neurological operate and high quality of life. Kids make up 27% of the world’s inhabitants, however most therapeutics for mind illness are examined on adults. Pediatric medical trials usually observe years later. This has led to a major hole in medical know-how for infants and youngsters. Nance’s analysis focuses on understanding the mind’s response to harm or illness and creating nanotherapeutic platforms to deal with mind illness utilizing nanotechnology, neurobiology and information science instruments.
Tag(s): School of Engineering • Division of Bioengineering • Division of Chemical Engineering • Elizabeth Nance • Valerie Daggett